Cargando…
Monitoring for Response to Antineoplastic Drugs: The Potential of a Metabolomic Approach
For most cancers, chemotherapeutic options are rapidly expanding, providing the oncologist with substantial choices. Therefore, there is a growing need to select the best systemic therapy, for any individual, that effectively halts tumor progression with minimal toxicity. Having the capability to pr...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746740/ https://www.ncbi.nlm.nih.gov/pubmed/29144383 http://dx.doi.org/10.3390/metabo7040060 |